Forecasting Diabetes Prevalence in California: A Microsimulation by Shi, Lu et al.
VOLUME 8: NO. 4, A80 JULY 2011
Forecasting Diabetes Prevalence in 
California: A Microsimulation
ORIGINAL RESEARCH
Suggested citation for this article: Shi L, van Meijgaard J, 
Fielding J. Forecasting diabetes prevalence in California: 
a microsimulation. Prev Chronic Dis 2011;8(4):A80. http://
www.cdc.gov/pcd/issues/2011/jul/10_0177.htm.  Accessed 
[date].
PEER REVIEWED
Abstract
Introduction
Setting a goal for controlling type 2 diabetes is important 
for  planning  health  interventions.  The  purpose  of  this 
study was to explore what may be a feasible goal for type 
2 diabetes prevention in California.
Methods
We used the UCLA Health Forecasting Tool, a microsimu-
lation model that simulates individual life courses in the 
population, to forecast the prevalence of type 2 diabetes in 
California’s adult population in 2020. The first scenario 
assumes no further increases in average body mass index 
(BMI)  for  cohorts  entering  adolescence  after  2003.  The 
second scenario assumes a gradual BMI decrease for chil-
dren entering adolescence after 2010. The third scenario 
builds on the second by extending the same BMI decrease 
to people aged 12 to 65 years. The fourth scenario builds 
on  the  third  by  eliminating  racial/ethnic  disparities  in 
physical activity. 
Results
We found the predicted diabetes prevalence of the first, 
second, third, and fourth scenarios in 2020 to be 9.93%, 
9.91%,  9.76%,  and  9.77%,  respectively.  We  found  obe-
sity prevalence for type 2 diabetes patients in 2020 to be 
34.2%, 34.0%, 25.7%, and 25.6% for the 4 scenarios. Life 
expectancy in the third (80.56 y) and fourth (80.94 y) sce-
narios compared favorably with that of the first (80.32 y) 
and second (80.32 y) scenarios. 
Conclusion
For the next 10 years, behavioral risk factor modifications 
are more likely to affect obesity prevalence and life expec-
tancy  in  the  general  population  and  obesity  prevalence 
among  diabetic  patients  than  to  alter  type  2  diabetes 
prevalence in the general population. We suggest setting 
more specific goals for reducing the prevalence of diabetes, 
such as reducing obesity-related diabetes complications, 
which may be more feasible and easier to evaluate than 
the omnibus goal of lowering overall type 2 diabetes preva-
lence by 2020.
Introduction
Prevalence  of  type  2  diabetes  among  California’s  adult 
population increased from 4.7% to 8.1% from 1994 to 2008 
(1). Reducing the prevalence of type 2 diabetes has been 
a  stated  goal  both  for  national  initiatives  like  Healthy 
People 2010 (2) and state-specific initiatives like Healthy 
California 2010 (3). However, numerical goals for disease 
prevalence levels in these initiatives are often set accord-
ing to the “better than the best” criterion (ie, the overall 
outcome for the entire future population should be at least 
better than the current level, as achieved by the best-per-
forming subpopulation). In the case of diabetes prevalence, 
“better than the best” translates to achieving a prevalence 
of 2.5% by 2010 (3).
Aspiring to be “better than the best” is a good approach 
with  regard  to  long-term  goals  for  disease  prevention. 
However, given the chronic nature of many medical con-
ditions — particularly in the case of type 2 diabetes, for 
which  there  is  no  proven  cure  —  10  years  may  not  be 
sufficient  time  for  the  overall  prevalence  to  drop  below 
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the current level for the subpopulation with the lowest 
prevalence. Milstein et al (4) demonstrated by using sys-
tems dynamics simulations that lowering the nationwide 
prevalence of diabetes from 2004 to 2010 was overly ambi-
tious, given the observed trend from 1980 to 2003. Even 
for behaviors like cigarette smoking, a scenario in which 
people frequently quit, a goal of “better than the best” has 
been shown to be unattainable within 10 years (5,6).
California’s diabetes risk profile is different from that of 
the rest of the United States, in part because of the state’s 
higher proportion of Latinos, higher proportion of people 
without a high school diploma, and younger average age 
(7-9).  Therefore,  establishing  and  evaluating  a  state-
specific goal of lowering prevalence of type 2 diabetes is 
important. We used the UCLA Health Forecasting Tool 
(UCLA-HFT) to project the prevalence of type 2 diabetes 
in California for the year 2020 and examine the potential 
effect of risk factor modifications on the forecasted preva-
lence of diabetes. The objective of this study was to exam-
ine whether reducing the prevalence of type 2 diabetes by 
2020 can be achieved by modifying obesity and physical 
activity rates in the California population.
Methods
The UCLA-HFT is a microsimulation model calibrated to 
represent demographics and population health, including 
health behaviors and disease outcomes, for county-, city-, 
and state-level populations in the United States. Age, race, 
and sex are set as demographic predictors of one’s diabetes 
incidence, whereas cigarette smoking, physical activity, and 
body mass index (BMI) are set as behavioral risk factors 
that affect both the diabetes onset for people without diabe-
tes and the diabetes case fatality for people with diabetes. 
Details of this model have been described elsewhere (10).
We used the UCLA-HFT to forecast prevalence of type 2 
diabetes among California’s adult population under dif-
ferent scenarios in 2020 (Table 1). The first scenario (the 
baseline scenario) built on recent observations that rates 
of childhood overweight and obesity have been leveling off 
in California and nationwide (11,12), assuming no further 
increase in obesity rates for the cohorts entering adoles-
cence (defined as being aged 12 to 17 years) after 2003, 
when obesity rates first started leveling. In other words, in 
this baseline scenario, all cohorts that reach age 12 years 
after 2003 have the same BMI distribution as the cohort 
that turned age 12 in 2003.
The  second  scenario  (called  “childhood  BMI  decrease”) 
was built on the observation that a considerable decline in 
rates of overweight and obesity in California has occurred 
among young children but not yet among adolescents (11). 
This scenario assumed a constant annual decrease in the 
BMI for children entering adolescence after 2010, until 
the  12-year-olds  in  2028  have  the  same  BMI  distribu-
tion as 12-year-olds in 1985. In other words, we modeled 
a  gradual  return  of  obesity  rates  to  the  1985  level  by 
assuming a small annual reduction of BMI for every new 
cohort of 12-year-olds. Thus, the mean BMI decline for 
each subsequent cohort entering adolescence from 2010 
to 2028 will be equivalent to the annual increase in mean 
BMI that was observed from 1985 to 2003. In our model, 
this cohort effect was modeled as a trend in the mean of 
the  inverse  of  BMI,  following  other  published  research 
(13,14), increasing by 3.1 x 10-4 annually for boys aged 
12 and increasing by 4.5 x 10-4 annually for girls aged 12. 
This increase in the mean of the inverse of BMI trans-
lates into an annual decrease in BMI of approximately 
0.19 kg/m2 for boys with an initial BMI of 25.0 kg/m2 and 
a decrease of 0.18 kg/m2 for girls with an initial BMI of 
25.0 kg/m2. The rate of decrease is higher for those with 
higher BMI initially because we modeled a mean shift in 
the inverse of BMI.
The  third  scenario  (called  “childhood  and  adult  BMI 
decrease”) made a more optimistic assumption for obesity 
control, assuming that annual BMI decline occurs not only 
among new cohorts of 12-year-olds every year (as in the 
second scenario), but also among adults aged 18 to 65 years 
who are overweight or obese. This scenario was simulated 
by assuming an annual BMI decrease for overweight and 
obese people from 2010 to 2028. The average annual BMI 
decrease was further assumed to be equivalent to the aver-
age annual BMI increase from 1985 to 2003. In our model, 
this was implemented as a stochastic increase in inverse 
BMI for people with a BMI more than 25.0 kg/m2 in the 
year.  The  inverse  BMI  increase  is  normally  distributed 
with a mean of 1.4 x 10-4 and a standard error of 0.6 x 10-4 
for men and a mean of 2.0 x 10-4 and a standard error of 
0.9 x 10-4 for women. This translates into a mean annual 
BMI decrease of 0.13 kg/m2 for men with an initial BMI of 
30.0 kg/m2 and 0.18 kg/m2 for women with an initial BMI 
of 30.0 kg/m2, with a larger decrement for those with a 
higher initial BMI.
The fourth scenario (called “BMI decrease with increase in 
PA levels”) built on the third scenario by further assuming 
an increase of physical activity levels such that racial/eth-VOLUME 8: NO. 4
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nic disparities in physical activity levels are eliminated, an 
objective specified by public health professionals (15). As 
estimated from the Behavioral Risk Factor Surveillance 
System of the Centers for Disease Control and Prevention, 
non-Hispanic  whites  (50%)  are  more  likely  to  meet  the 
federal guideline (16) of at least 150 minutes per week 
of moderate-intensity physical activity or 75 minutes per 
week  of  vigorous-intensity  physical  activity  than  other 
racial/ethnic  minority  groups  (African  Americans,  37%; 
Latinos, 37%; Asians, 40%) (17).
Under this fourth scenario, starting from 2011, for each 
sex-age stratum all racial/ethnic subpopulations achieve 
the same physical activity level as the most active sub-
population in 2010.
We compared 4 simulated outcomes across the scenarios: 
type 2 diabetes prevalence among adults, obesity preva-
lence among adults, obesity prevalence among people with 
diabetes, and life expectancy at birth.
Results
In 2008, type 2 diabetes prevalence among the adult popu-
lation in California reached 8.1% (1). In none of the simu-
lated scenarios did type 2 diabetes prevalence decrease 
below this level. The predicted type 2 diabetes prevalence 
in 2020 for the baseline scenario and for scenarios 2, 3, 
and 4 was 9.93%, 9.91%, 9.76%, and 9.77%, respectively 
(Table 2).
According to the baseline scenario, California’s adult obe-
sity prevalence will rise to 30.8% in 2020. This increase 
was attenuated in scenarios 2, 3, and 4, the largest reduc-
tion occurring in the third scenario in which an overall 
decrease in BMI and an increase in physical activity levels 
was  applied  (10.8  percentage  points  below  the  baseline 
prevalence). Among people with diabetes, obesity preva-
lence was 34.2% in the baseline scenario and decreased in 
all subsequent scenarios.
Life expectancy at birth was calculated by using age-spe-
cific death rates for the California population in 2020. In 
the baseline scenario, life expectancy was predicted to be 
80.32 years. In the second scenario, in which a reduction in 
BMI for adolescents was applied, a reduction in life expec-
tancy was not realized. Scenarios 3 and 4 yielded a gain in 
life expectancy of 0.24 year and 0.62 year.
Discussion
To the best of our knowledge, this is the first study to use 
microsimulation to forecast trends in type 2 diabetes prev-
alence. Although we modeled ideal intervention scenarios, 
we found that these scenarios did not yield appreciably 
lower prevalence estimates for type 2 diabetes by 2020, 
compared with the baseline scenario. Furthermore, none 
of these scenarios projected a diabetes prevalence lower 
than that of the actual 2008 prevalence of 8.1%. These 
findings are similar to insights by Jones et al (18) that a 
considerable delay exists between primary prevention and 
downstream  improvements  in  diabetes  outcomes.  Even 
effective prevention approaches in lifestyle modification to 
reduce obesity only slowed the increase of type 2 diabetes 
prevalence, at least for the first 10 years.
Unlike the systems dynamics model by Jones et al (18) in 
which obesity reduction nationwide from 2006 could lead 
to a “tipping point” of diabetes prevalence in 2018, none of 
our scenarios predicted such a point by 2020 for California. 
In  our  model,  the  changing  demographics  of  the  state, 
the aging of the California population, and the increasing 
proportion of high-risk demographic groups in the state all 
contributed to the increase of type 2 diabetes prevalence. 
Given the simulated individual life courses in our model, 
the increase in obesity prevalence starting in the 1980s 
affects future diabetes incidence, as the younger cohorts, 
for which overweight and obesity began to be epidemic, 
enter their 50s and 60s when type 2 diabetes prevalence 
rises rapidly. Therefore, the positive effect of risk factor 
modifications manifested in the lowered obesity prevalence 
among the adult population and reduced complications of 
obesity and diabetes in the third and fourth scenarios but 
did not decrease diabetes prevalence below the actual 2008 
level. Our model confirms the findings of a study by Jones 
et al (18) that a reduction in obesity prevalence translates 
very slowly into a reduction in type 2 diabetes prevalence. 
Incorporation  of  demographic  transition  adds  another 
component to this and other simulations when substantial 
variations in risk factors and baseline disease rates exist 
across age and race subgroups.
Another reason that obesity and physical activity inter-
ventions are not forecasted to lower type 2 diabetes preva-
lence from the 2008 level of 8.1% is that these interven-
tions not only help prevent diabetes but also reduce the 
complication rates for diabetic patients. A leaner and more 
active population of patients with type 2 diabetes will live 
longer (19-23), so the reduction in new cases due to pre-VOLUME 8: NO. 4
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vention are offset by longer life in those with the disease. 
Moreover,  although  the  prevention  effect  of  behavioral 
changes is confined to type 2 diabetes, both of the risk fac-
tor reductions increase the survival of patients with type 1 
and type 2 diabetes. This counterintuitive result, whereby 
behavioral improvement could increase the prevalence of 
an epidemic, is best illustrated by the fact that adding a 
physical activity increase to the “childhood and adult BMI 
decrease”  scenario  slightly  increases  the  obesity  preva-
lence among the general adult population (Table 2).
This study has limitations. First, our model does not con-
sider the behavioral mechanism whereby a prediabetes or a 
gestational diabetes diagnosis may trigger lifestyle change 
and pharmacologic treatment that could considerably reduce 
the onset probability of type 2 diabetes among people most 
at risk. A major lifestyle change among people most at risk 
for type 2 diabetes could have more immediate effect on 
incidence reduction than a lifestyle change randomly dis-
tributed among the general population. Second, we discuss 
only the outcome of obesity prevalence among patients with 
diabetes when we consider the effect of lifestyle changes on 
the health status of this group, although lifestyle changes 
such as physical activity increase may improve patients’ 
quality of life in ways other than BMI reduction. A more 
comprehensive outcome metric is needed to better account 
for  the  overall  effect  of  behavioral  modifications  on  the 
health status of patients with type 2 diabetes.
A continuing observed rise in type 2 diabetes prevalence 
among the adult population in the coming decade does not 
necessarily reflect unsuccessful prevention interventions. 
It takes longer than a decade for risk factor modifications 
of  historically  reasonable  amplitude  to  decrease  type  2 
diabetes prevalence. The effects of behavioral risk factor 
modifications are more rapidly observed in outcomes such 
as obesity prevalence and life expectancy, as well as in the 
complications of obesity and type 2 diabetes. In the case 
of diabetes control, more specific goals such as improving 
early detection of diabetes cases (as specified in Healthy 
California  2010),  decreasing  gestational  diabetes  (24), 
and reducing obesity-diabetes complications may be more 
feasible and easier to evaluate than the omnibus goal of 
lowering type 2 diabetes prevalence by 2020.
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Tables
Table 1. Assumptions of Future Obesity and Physical Activity Trends for the 4 Simulation Scenarios, California
Scenario Assumption for Body Mass Index (BMI) Distributions
Assumption for Disparities in Physical Activity (PA) 
Levels
1. Baseline All cohorts that become aged 12 years after 200 have the same BMI distribu-
tion as the cohort turning 12 years in 200
Disparities in PA levels will exist in the population as 
they did before
2. Childhood 
BMI decrease
Cohorts that become aged 12 years between 200 and 2010 have the same 
BMI distribution as the cohort turning 12 years in 200. After 2010, there is 
an annual decrease in BMI for children entering adolescence, until the 12-year-
olds in 2028 have the same BMI distribution as those in 198
Disparities in PA levels will exist in the population as 
they did before
. Childhood 
and adult BMI 
decrease
The same as in “Childhood BMI decrease” scenario, plus a decline in BMI 
(equal to calibrated annual BMI increase from 198 to 200) among every per-
son aged 12 to 6 years after 2010, except for those who are underweight
Disparities in PA levels will exist in the population as 
they did before
4. BMI decrease 
with increase in 
PA levels
The same as in “BMI decrease 12 to 6” scenario In 2011, all subpopulations achieve the same PA 
levels as the most active subpopulation in 2010 (ie, 
disparities are eliminated)VOLUME 8: NO. 4
JULY 2011
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Table 2. Simulated Health Outcomes for the Adult Population of California Under 4 Scenarios in the Year 2020a
Health Outcome
Scenario
1. Baseline
2. Childhood BMI 
Decrease
3. Childhood and Adult 
BMI Decrease
4. BMI Decrease With 
Increase in PA Levels
Diabetes prevalence, % 9.9 9.91 9.76 9.77
Difference from baseline NA −0.02 −0.17 −0.16
Obesity prevalence, % 0.8 27.2 20.0 22.2
Difference from baseline NA −3.6 −10.8 −8.6
Obesity prevalence among people 
with diabetes, %
4.2 4.0 2.7 2.6
Difference from baseline NA −0.2 −8.5 −8.6
Life expectancy at birth, y 80.2 80.2 80.6 80.94
Difference from baseline NA 0 0.24 0.62
 
Abbreviation: BMI, body mass index; PA, physical activity; NA, not applicable. 
a The definitions of each scenario are given in Table 1.